Tom McDonald
Finanzdirektor/CFO bei Genomatica, Inc.
Ursprung des Netzwerks ersten Grades von Tom McDonald
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Genomatica, Inc.
Genomatica, Inc. BiotechnologyHealth Technology Genomatica, Inc. designs and develops biotechnology products. It offers metabolic engineering for renewable production of commodity chemicals. The company was founded by Bernhard O. Palsson and Christophe H. Schilling in 1998 and is headquartered in San Diego, CA.
28
| Holding Company | Biotechnology | 28 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tom McDonald
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
EASTMAN KODAK COMPANY | Industrial Machinery | Chief Tech/Sci/R&D Officer | |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal | |
STANDARD BIOTOOLS INC. | Medical Specialties | Director/Board Member | |
AMYRIS, INC. | Chemicals: Specialty | Director/Board Member Corporate Officer/Principal | |
GEVO, INC. | Chemicals: Specialty | Chairman Director/Board Member Corporate Officer/Principal | |
LYONDELLBASELL INDUSTRIES N.V. | Chemicals: Specialty | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
INVITAE CORPORATION | Medical/Nursing Services | Director/Board Member | |
AllianceBernstein LP
AllianceBernstein LP Investment ManagersFinance AllianceBernstein LP (AB) is a SEC-registered investment advisor and mutual fund manager headquartered in Nashville, Tennessee. Founded in 2000, the firm is owned by Equitable Financial Life Insurance Co., ultimately held by Equitable Holdings, Inc. (NYSE: EQH). AB provides investment advice to investment companies, pension and profit-sharing plans, banks and thrift institutions, trusts, estates, government agencies, charitable organizations, individuals, corporations and other business entities. | Investment Managers | Analyst-Equity | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
TATE & LYLE PLC | Food: Specialty/Candy | Chief Tech/Sci/R&D Officer | |
University of California, Los Angeles | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
The University of Chicago | College/University | Masters Business Admin | |
University of Kentucky | College/University | Undergraduate Degree | |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Medical Specialties | Director/Board Member | |
The Rockefeller University | College/University | Director/Board Member | |
VERENIUM CORP | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Michigan Biotechnology Institute | Corporate Officer/Principal | ||
National Institute of Clean & Low Carbon Energy | President | ||
Casdin Capital LLC
Casdin Capital LLC Investment ManagersFinance Casdin Capital LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Eli Casdin in 2012. They provide investment management services to pooled investment vehicle, or more specifically, a private investment fund, the securities of which are offered to certain qualified investors on a private placement basis. | Investment Managers | Founder | |
Verana Health, Inc.
Verana Health, Inc. Packaged SoftwareTechnology Services Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Columbia University School of the Arts | College/University | Director/Board Member | |
Imagen Technologies, Inc.
Imagen Technologies, Inc. Packaged SoftwareTechnology Services Imagen Technologies, Inc. operates as a medical technology company that develops and offers devices for the prevention of diagnostic errors. The company was founded by Alexander Dresner, Robert Lindsey, Thomas Stuart Hotchkiss and Sumit Chopra in 2015 and is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
Vineti, Inc.
Vineti, Inc. Medical/Nursing ServicesHealth Services Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA. | Medical/Nursing Services | Director/Board Member | |
RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Genome Medical, Inc.
Genome Medical, Inc. Information Technology ServicesTechnology Services Genome Medical Holding Co. operates tele genomics platform which allows genetic experts to consult with patients and physicians across the country. The firm specializes in genomics, genetics, precision medicine, medical practice, personalized medicine, genetic counseling, DNA and genome. The company was founded by Lisa J. Alderson, Robert C. Green and Randal W. Scott in 2016 and is headquartered in South San Francisco, CA. | Information Technology Services | Director/Board Member | |
Casdin Partners Offshore Ltd.
Casdin Partners Offshore Ltd. Investment Trusts/Mutual FundsMiscellaneous Casdin Partners Offshore Ltd. operates as a hedge fund. The company is headquartered in George Town, Cayman Islands. | Investment Trusts/Mutual Funds | Director/Board Member | |
Paige.Ai, Inc.
Paige.Ai, Inc. Miscellaneous Commercial ServicesCommercial Services Paige Ai, Inc. engages in revolutionizing pathology and strengthen lynchpin of medical diagnostics with quantitative, computational technology, fusing machine learning, and human expertise. It involves in building an artificial intelligence to change clinical diagnosis and treatment of cancer. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Snap Bio, Inc.
Snap Bio, Inc. BiotechnologyHealth Technology Snap Bio, Inc. develops next-generation therapeutics. It discovers new therapeutics for oncology. The company is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
CENTURY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
2SEVENTY BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Mnemo Therapeutics SAS
Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
GENEDX HOLDINGS CORP. | Medical/Nursing Services | Director/Board Member | |
STANDARD BIOTOOLS INC. | Miscellaneous Commercial Services | Director/Board Member | |
EQRX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Leyden Labs
Leyden Labs BiotechnologyHealth Technology Leyden Labs develops preventive medicines that target respiratory viruses. The private company is based in Leiden, Netherlands. | Biotechnology | Director/Board Member | |
IDRx, Inc.
IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Vereinigte Staaten | 42 |
Vereinigtes Königreich | 3 |
Kanada | 2 |
Dänemark | 2 |
China | 2 |
Sektoral
Health Technology | 15 |
Finance | 7 |
Commercial Services | 7 |
Consumer Services | 7 |
Process Industries | 6 |
Operativ
Director/Board Member | 129 |
Corporate Officer/Principal | 66 |
Independent Dir/Board Member | 22 |
Chairman | 21 |
Undergraduate Degree | 20 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Eli Casdin | 48 |
Geoff Duyk | 42 |
J. Read | 27 |
William Baum | 16 |
Michael E. Keane | 14 |
Carlos A. Cabrera | 13 |
Josh L. Green | 11 |
Thomas J. G. Huot | 11 |
Just Jan Christiaan Jansz | 9 |
Jefferson Lievense | 8 |
Dennis McGrew | 8 |
Shawnte Mitchell | 8 |
Mark J. Burk | 8 |
Rasmus Gottberg | 8 |
Damien A. Perriman | 7 |
- Börse
- Insiders
- Tom McDonald
- Unternehmensverbindungen